Who are Polyethylene Glycols's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pizensy, Miralax, Cephulac, Milk of Magnesia, Standard full-volume PEG, SUPREP Bowel Prep Kit.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyethylene-glycols.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Polyethylene Glycols — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polyethylene Glycols (Polyethylene Glycols) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative. Area: Gastroenterology.

marketed Osmotic laxative Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Polyethylene Glycols (Polyethylene Glycols) — Tomas Bata Hospital, Czech Republic. Polyethylene glycols act as osmotic laxatives that draw water into the intestinal lumen to promote bowel movements.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Polyethylene Glycols TARGET	Polyethylene Glycols	Tomas Bata Hospital, Czech Republic	marketed	Osmotic laxative
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Standard full-volume PEG	Standard full-volume PEG	Kyunghee University Medical Center	marketed	Osmotic laxative	Intestinal lumen
SUPREP Bowel Prep Kit	SUPREP Bowel Prep Kit	Braintree Laboratories	marketed	Osmotic laxative	Intestinal lumen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-03-09 — Miralax · 10780112 · US
2032-03-09 — Miralax · 11529368 · US
2032-03-09 — Miralax · 10792306 · US
2032-03-25 — Miralax · 10646512 · US
2032-08-11 — Miralax · 9592252 · US
2033-09-10 — Miralax · 9326969 · US
2033-09-10 — Miralax · 9707297 · US
2033-09-10 — Miralax · 8999313 · US
2033-09-10 — Miralax · 10918723 · US
2033-09-10 — Miralax · 10016504 · US

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polyethylene Glycols — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycols. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing